CIK 0001840439 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $8.68 ($86,767)
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy 10% owner bought 34,658 shares at $10.96 ($379,852)
- 4 Open-market buy Director bought 34,658 shares at $10.96 ($379,852)
- 8-K Event Other events
- 4 Open-market buy President & COO bought 24,000 shares at $13.20 ($316,872)
- 4 Open-market buy CEO bought 24,000 shares at $13.20 ($316,872)
Page 12 of 15 · 292 filings